Search Results
Found 1 results
510(k) Data Aggregation
(138 days)
NEXWAVE COMBO MUSCLE STIMULATOR SYSTEM
Interferential Mode (IFC)
- . Symptomatic relief of chronic intractable pain, post-traumatic and postsurgical pain.
Neuromuscular Electrical Stimulation Mode (NMES) - . Muscle Re-education
- . Prevention or Retardation of Disuse Atrophy
- . Increasing Local Blood Circulation
- . Maintaining or Increasing Range of Motion
- . Relaxation of Muscle Spasms
Transcutaneous Electrical Nerve Stimulation Mode (TENS) - . Management and Symptomatic Relief of Chronic Intractable Pain, Posttraumatic and Post-surgical Pain.
Combination Neuromuscular Electrical Stimulator, Interferential Stimulator, and Transcutaneous Electrical Nerve Stimulator, Model NexWave.
I am sorry, but the provided text from the FDA 510(k) letter for the Zynex Medical Combination Neuromuscular Electrical Stimulator, Interferential Stimulator, and Transcutaneous Electrical Nerve Stimulator, Model NexWave (K111279) does not contain information about acceptance criteria or a study that proves the device meets specific acceptance criteria.
The document is a letter from the FDA to Zynex Medical, informing them that their device has been found substantially equivalent to legally marketed predicate devices. It outlines the regulatory classification, general controls provisions, and refers to the indications for use.
Crucially, it does not describe any specific performance study, clinical trial data, or detailed technical specifications related to the device's accuracy, efficacy metrics, or statistical results that would allow me to populate the requested table and answer the study-related questions. The letter focuses on the regulatory determination of substantial equivalence, not on a detailed performance evaluation report.
Therefore, I cannot provide the requested information based on the text provided.
Ask a specific question about this device
Page 1 of 1